← back to search

Vivien Low

Memorial Sloan Kettering Cancer Center · US
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Pancreatic and Hepatic Oncology Research, Epigenetics and DNA Methylation, and Pancreatic function and diabetes.
h-index
12
citations
1,151
works
29
NIH funding
primary concept
email

Recent publications

The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer
Cell Metabolism 2025cited by 20position: middledoi
Stromal KITL/SCF Maintains Pancreas Tissue Homeostasis and Restrains Tumor Progression
Cancer Discovery 2025cited by 3position: middledoi
NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis
Redox Biology 2023cited by 34position: middledoi
Altered propionate metabolism contributes to tumour progression and aggressiveness
Nature Metabolism 2022cited by 107position: middledoi
Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression
Nature Communications 2022cited by 64position: middledoi
Metabolite activation of tumorigenic signaling pathways in the tumor microenvironment
Science Signaling 2022cited by 43position: firstdoi
Decreased Enterobacteriaceae translocation due to gut microbiota remodeling mediates the alleviation of premature aging by a high‐fat diet
Aging Cell 2022cited by 30position: middledoi
Age-induced accumulation of methylmalonic acid promotes tumour progression
Nature 2020cited by 245position: middledoi
Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization
Cancer Cell 2019cited by 100position: middledoi
Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization
Cancer Cell 2018cited by 196position: middledoi
Control of Embryonic Stem Cell Identity by BRD4-Dependent Transcriptional Elongation of Super-Enhancer-Associated Pluripotency Genes
Cell Reports 2014cited by 218position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John Blenis · Cornell University7 papers (2018–2025)Tanya Schild · Memorial Sloan Kettering Cancer Center6 papers (2018–2023)Ana P. Gomes · Moffitt Cancer Center5 papers (2018–2023)Didem Ilter · Moffitt Cancer Center4 papers (2019–2023)Zhongchi Li · Cornell University4 papers (2022–2025)Lewis C. Cantley · Meyer (China)4 papers (2019–2022)Julie Han · Cornell University3 papers (2019–2022)Noah Dephoure · Arup Group (United States)3 papers (2019–2022)Adam Rosenzweig · Tri-Institutional PhD Program in Chemical Biology3 papers (2019–2022)Edouard Mullarky · Cornell University3 papers (2019–2022)John M. Asara · Harvard University3 papers (2020–2023)Anders P. Mutvei · Karolinska Institutet3 papers (2019–2022)Sungyun Cho · Korea University2 papers (2022–2022)Dorien Broekaert · KU Leuven2 papers (2020–2022)Ilaria Elia · KU Leuven2 papers (2020–2022)Stanislav Drápela · Medical University of South Carolina2 papers (2022–2023)Michal J. Nagiec · Cornell University2 papers (2019–2022)Sarah‐Maria Fendt · VIB-KU Leuven Center for Cancer Biology2 papers (2020–2022)Jennifer E. Endress · Weill Cornell Medicine2 papers (2020–2022)Paola Cavaliere · Cornell University1 papers (2019–2019)